BioHarvest Sciences Inc.

GRI Bio, Inc.

Cartesian Therapeutics, Inc.

Viridian Therapeutics, Inc.

Jazz Pharmaceuticals plc

Compass Therapeutics, Inc.

SpyGlass Pharma, Inc.

Summit Therapeutics Inc.

Generate Biomedicines, Inc.

Dilution score: 46/100 (MEDIUM), None months cash

13F fund flow: neutral, ? institutional managers

243714 PubMed publications found for BioHarvest Sciences .

Emerging role of herbal nanogel formulations in skin cancer therapy: mechanistic insights and translational advances in nanomedicine.

Pretreatment HIV-1 drug resistance and molecular subtype characteristics among newly diagnosed individuals in Guangxi, China.

Personality-based subgroup identification and psychological symptom patterns in adolescent male new psychoactive substance users: implications for targeted intervention.

Association of serum BMP2 with delayed memory impairment in first-episode, drug-naïve schizophrenia.

Correction: Altered microbial cargo in fecal microbiome-derived outer membrane vesicles as novel biomarkers for vascular dementia.

Short interest: 0.4% of float, squeeze risk: MODERATE

SW convergence: 50/100 (Neutral), 1 bullish / 0 bearish signals

<article class="bts-verified-summary" data-ticker="BHST">
<p>BioHarvest Sciences Inc. (BHST) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.</p>
<p>No Form 4 insider filings for BHST were recorded at the SEC in the past 30 days<sup><a href="#fn-1">[1]</a></sup>.</p>
<section class="sources" data-nosnippet aria-label="Sources"><h3>Sources</h3><ol><li id="fn-1">SEC EDGAR · 0001723464 (2026-06-17) <a href="https://efts.sec.gov/LATEST/search-index?q=%22BHST%22&amp;forms=4&amp;dateRange=custom&amp;startdt=2026-05-18&amp;enddt=2026-06-17" rel="nofollow noopener noreferrer">↗</a></li></ol></section>
</article>

SEC EDGAR — 0001723464

BioHarvest Sciences Inc. (BHST) — BioTechSigns Verified Summary

BioHarvest Sciences Inc. (BHST) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.

No Form 4 insider filings for BHST were recorded at the SEC in the past 30 days[1].

Sources:
[1] SEC EDGAR, 0001723464. Source last updated 2026-06-17, retrieved 2026-06-17.
    https://efts.sec.gov/LATEST/search-index?q=%22BHST%22&forms=4&dateRange=custom&startdt=2026-05-18&enddt=2026-06-17